Dyne is an opportunity to take cutting-edge nucleic acid-based therapeutics and use our understanding of human biology to overcome the next set of hurdles in precision medicine. The team being built at Dyne is perfectly positioned to develop novel therapeutics for rare diseases, and I am ecstatic to have the opportunity to be a part of it.